Catchword developed a name for the first and only eye drop to treat presbyopia (age-related blurry near vision) for global pharmaceutical leader Allergan (part of AbbVie)."Vuity" instantly conveys the solution’s ability to improve viewing acuity and clarity. The name is easy to spell and say (no small feat in pharmaceutical naming) and works equally well for English-speaking and international audiences. The name’s smoothly voiced opening “V” suggests velocity, action, and efficiency, ideas reinforced by the word’s brevity.
Catchword is one of the world's leading brand naming agencies, with more than 20 years' experience in every aspect of name development – naming strategy and architecture, product and company naming, linguistic and legal screening, and domain acquisition. Catchword's engagements range from quick-turnaround projects with startups to retainer relationships with Fortune 500s. From offices in the San Francisco Bay Area and New York City, Catchword's award-winning team of strategists, linguists, and storytellers have delivered 1,000+ successful, ownable names to clients in every sector.